Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > Cancel Early Christmas Present
View:
Post by WarrantOfficer on Nov 27, 2024 9:33am

Cancel Early Christmas Present

WIth so many factors on Voyageurs side and the soon to be released full product line,  I ponder as to why they cannot close a million dollar raise in 6 weeks. Miners running a pharma company, kind of like the fire department running the post office..........Blue sky potential remains. 
Comment by crammer11 on Nov 27, 2024 10:59am
Yes was thinking of loading up. Why no interest here
Comment by postie1 on Nov 27, 2024 4:34pm
Just my opinion and others can add or give a different one. There are a lot of small investers in VM and on this board.May be they have a limited amount of money and/or they already  have an oversize position in VM Plus there are people who already have large stakes.Investers can get nervous about putting too many eggs in one basket. As shown by the lack of shares being traded when the price ...more  
Comment by biggdogg on Nov 28, 2024 1:50pm
As far as I am concerned, I hope they raise just enough to get to revenue and not the full amount, the less dilution the better. I think Q1 the stock will be higher and more attractive as financing under the $10M market cap size is very difficult and most finance companies cant touch it. They need to get over $20M market cap to attract institutions. With some revenue everything changes. They ...more  
Comment by JrOGInvestor on Nov 28, 2024 9:01pm
Fair point, although they are already a third of the way there with the latin america deal. Every province in Canada is 'low hanging fruit' then they can market to roughly 25 countries that accept Health Canada Approvals. By then they should be ready to break into the US market. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1